News FDA Revises Evusheld EUA Halting Use of the COVID-19 Therapy for Now By Diana Ernst, RPh Publish Date January 26, 2023
News FDA Panel Votes on Rezafungin for Treatment of Candidemia, Invasive Candidiasis By Diana Ernst, RPh Publish Date January 25, 2023
News Uptake Low for COVID-19 Vaccine Boosters in Immunocompromised Adults Publish Date January 25, 2023
News Seniors Had High Burden of RSV-Positive Respiratory Infection Before COVID-19 Publish Date January 24, 2023
News Two Cases of New Drug-Resistant Gonorrhea Strain Reported in Massachusetts Publish Date January 23, 2023
News Respiratory Virus Coinfection May Up SARS-CoV-2 Severity in Children Under 5 Publish Date January 19, 2023
News FDA Clears Test to Aid in Early Detection of Sepsis By Diana Ernst, RPh Publish Date January 18, 2023
Drugs in the Pipeline Lack of Efficacy Ends Trial Evaluating Janssen’s HIV Vaccine Candidate By Brian Park, PharmD Publish Date January 18, 2023
News Fluvoxamine Does Not Improve Time to Sustained Recovery in Mild COVID-19 Publish Date January 13, 2023
Drugs in the Pipeline December 2022 Recap: Drug Pipeline Updates By Brian Park, PharmD Publish Date January 11, 2023
Drugs in the Pipeline FDA to Review 20-Valent Pneumococcal Conjugate Vaccine for Pediatric Use By Brian Park, PharmD Publish Date January 6, 2023
News Discontinuation of Several HIV Medications Reported to FDA By Diana Ernst, RPh Publish Date January 4, 2023